Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen
Clinical trial NCT04346615 · TERMINATED
Trial details
- NCT number
- NCT04346615
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-25
- Primary completion
- 2022-04-29
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.